Enzalutamide is approved by the FDA for the treatment of men with metastatic castrate-resistant prostate cancer that is no longer responding to chemotherapy.
Enzalutamide
$3,870.72 – $9,999.36
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.